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including highly debilitating neurodegenerative disorders and systemic amyloidoses. It is widely accepted that small oligomers
arising as intermediates in the aggregation process, released by fibrils, or growing in secondary nucleation steps are the cyto-
toxic entities in protein-misfolding diseases, notably neurodegenerative conditions. Increasing evidence indicates that cytotox-
icity is triggered by the interaction between nanosized protein aggregates and cell membranes, even though little information on
the molecular details of such interaction is presently available. In this work, we propose what is, to our knowledge, a new
approach, based on the use of single-cell force spectroscopy applied to multifunctional substrates, to study the interaction be-
tween protein oligomers, cell membranes, and/or the extracellular matrix. We compared the interaction of single Chinese ham-
ster ovary cells with two types of oligomers (toxic and nontoxic) grown from the N-terminal domain of the Escherichia coli protein
HypF. We were able to quantify the affinity between both oligomer type and the cell membrane by measuring the mechanical
work needed to detach the cells from the aggregates, and we could discriminate the contributions of the membrane lipid and
protein fractions to such affinity. The fundamental role of the ganglioside GM1 in the membrane-oligomers interaction was
also highlighted. Finally, we observed that the binding of toxic oligomers to the cell membrane significantly affects the function-
ality of adhesion molecules such as Arg-Gly-Asp binding integrins, and that this effect requires the presence of the negatively
charged sialic acid moiety of GM1.INTRODUCTIONThe self-assembly of peptide/protein molecules from their
native states into well-defined fibrillar aggregates in
human tissues is associated with a number of degenerative
pathologies, including Alzheimer’s, Parkinson’s, Hunting-
ton’s diseases, several systemic amyloidoses, and many
others (1). In many such diseases, particularly in neurode-
generative conditions, it is currently believed that an
important cytotoxic role is played by small protein oligo-
mers that accumulate as on- or off-pathway species during
fibril formation (2–5), can be released by leakage from
mature amyloid fibrils (2,6–8), or can result as a conse-
quence of secondary nucleation at the surface of pre-
formed fibrils (9–12).Submitted August 31, 2017, and accepted for publication February 2, 2018.
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 2018The two oligomeric forms, named type A oligomer (OA)
and type B oligomer (OB) and grown under different
solution conditions from the N-terminal domain of the
Escherichia coli protein HypF (HypF-N), have provided a
remarkable contribution to our understanding of the olig-
omer structure-cytotoxicity relationship (13–20). In partic-
ular, this system has allowed us to gain significant insight
into the structural and biophysical determinants underlying
the interaction of protein-misfolded oligomers with the cell
membrane, in most cases the earliest event in oligomer-
mediated cytotoxicity (13–20). Both OAs and OBs bind
weakly, but significantly, to thioflavin T and display a
roughly spherical shape with a height of 2–6 nm as deter-
mined by atomic force microscopy (AFM) (13). However,
only OAs were found to be cytotoxic when added to the
extracellular medium of cultured cells (13–15,17,20) or in-
jected into rat brain (19,20), similarly to oligomers found in
other amyloid diseases (21). It is just the toxic and nontoxicBiophysical Journal 114, 1357–1367, March 27, 2018 1357
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comparative study of the two forms have provided an impor-
tant contribution to the elucidation of the oligomer struc-
tural determinants underlying their toxicity and eventually
culminating with cell dysfunction and death (13–20,22).
Previous experimental evidence suggested that the
different toxicities of OA and OB are attributable to the
higher solvent-exposure of hydrophobic amino acid residues
in the former with respect to the latter (13). At micromolar
concentrations, both OA and OB interact with the cell mem-
brane of cultured cells, but only OAs destabilize the mem-
brane, causing several biochemical modifications that
eventually lead to cell failure (20). Subsequent studies
showed that the interaction of OAs with the cell membrane
occurs at lipid rafts (membrane lipid domains enriched in
cholesterol, sphingolipids, and the GM1 ganglioside), and
that such interaction is mediated particularly by the latter
(14,15,18). The use of different forms of oligomers of the
Ab42 peptide (named Aþ and A (23)) with different struc-
tural properties and cytotoxicity yielded comparable results,
further highlighting the importance of solvent-exposed
hydrophobic clusters as well as oligomer-membrane inter-
action and lipid composition, particularly GM1 content, in
determining protein-oligomer cytotoxicity (14,15,24–26).
More generally, GM1 has been repeatedly shown to be
involved in amyloid fibril growth and recruitment of amyloi-
dogenic proteins to the cell membrane, supporting its
remarkable role in amyloid growth and cytotoxicity not
only in vitro but also in vivo (27–31). Moreover, the similar-
ity of the results obtained with the two types of HypF-N and
Ab42 oligomers supports the validity of using the former to
carry out further studies on the relationship between mem-
brane lipid composition/GM1 content on the one hand and
oligomer structure/physicochemical properties/toxicity on
the other.
A recent detailed study carried out by AFM imaging on
supported lipid bilayers (SLBs) has elucidated the different
ability of the two types of oligomers to interact with the
GM1-enriched gel phase domains (Lb domains) and/or the
fluid domains (La domains) of the bilayer (18). Interest-
ingly, OAs, but not OBs, were able to interact with both
La and Lb domains. In particular, OAs were found to pene-
trate the ordered Lb domains of the SLBs, whereas they
assembled into annular species in the fluid La domains.
The same study revealed that the cleavage and elimination
of the sialic acid group from GM1 in the Lb domains of
SLBs and in the lipid membrane rafts of cultured cells in-
hibited both the interaction of the OAs with the Lb domains
of the SLBs and their cytotoxicity (18). This finding indi-
cated that only the interaction of OA with the Lb phase
domains is responsible for cytotoxicity, and that this interac-
tion is driven by electrostatic attraction between the nega-
tively charged GM1 and the positively charged Hypf-N
(32). It also provided clues against the theory based on olig-
omer cytotoxicity through formation of annular doughnut-1358 Biophysical Journal 114, 1357–1367, March 27, 2018shaped oligomers in the cell membrane, in agreement with
recent data (33–36).
Oligomer toxicity has also been proposed to depend on the
interaction not only with the lipid fraction of the cell mem-
brane but also with membrane proteins most often located
within the lipid rafts (37). Preliminary data have reported
that both OAs and OBs interact with cell membrane proteins,
and that nontoxic OBs are stronger binders of proteins (un-
published data). Overall, both toxic OAs and nontoxic OBs
have been reported to interact with membrane protein com-
ponents, but only OAs appear to interact with the lipid
components of the cell membrane, and such interaction,
particularly when mediated by GM1 in the ordered-phase
domains of SLBs or in the lipid rafts of the cell membrane,
appears to be responsible for OA-mediated toxicity.
Early on, the scanning probe microscopy community
recognized the potential of AFM for measuring bond
strengths. Indeed, AFM has been widely used in the study
of intermolecular interactions, i.e., well-defined chemical
functionalities, protein-protein pairs, and colloidal particles
(38–43). The coupling with fluorescent optical microscopy
has been the most common solution exploited to overcome
the lack of chemical specificity of AFM (44–46). In this
work, we exploited a method based on single-cell force
spectroscopy (SCFS) (47–54) and previously described by
our group to investigate the adhesion of single cells on
multifunctional substrates (52) to study quantitatively the
mechanical forces associated with the interaction between
cell membranes and protein oligomers, which is a yet unex-
plored field. In particular, we characterized in more detail
the interaction force between toxic/nontoxic oligomers
and the cell membrane by using OA and OB as a model
of oligomers and Chinese hamster ovary (CHO) cells as a
probe. CHO cells are particularly suitable to this purpose
and have been widely employed in SCFS applications
(50,52,54,55). Furthermore, they have been also used as a
model system to test protein aggregate toxicity (56–58),
permitting a comparison of our data with those reported in
the literature. The interaction between OA/OB species and
the cell membrane was quantified as the mechanical work
needed to detach a number of individual protein aggregate
particles from the cell membrane. This approach allowed
the quantification of the relative affinities of the toxic OA
oligomers for the membrane lipid and protein fractions.
Our results also indicate the need of a deeper analysis on
the influence of OA/OB on the functionality of classes of
membrane molecules other than lipids and their interaction
with extracellular matrix components.MATERIALS AND METHODS
Preparation of HypF-N amyloid aggregates
HypF-N was purified, and its aggregated forms were obtained as previously
described (13). In brief, in the first conditions, defined as conditions A, we
HypF-N Oligomers Impair Cell Adhesionobtained OAs and type A fibrils (FAs), whereas in second conditions, con-
ditions B, we obtained OBs and type B protofibrils (PFBs). In type A con-
ditions, native HypF-N was diluted to 48 mM in 50 mM acetate buffer (pH
5.5) containing 12% (v/v) trifluoroethanol (Sigma-Aldrich, St. Louis, MO)
and 2.0 mM dithiothreitol (Sigma-Aldrich) and incubated for 4 h and
21 days at 25C, respectively. In the type B conditions, native HypF-N
was diluted to 48 mM in 20 mM trifluoroacetic acid (Sigma-Aldrich), and
330 mM NaCl (pH 1.7), followed by incubation at 25C for 4 h and
21 days, respectively. The samples were then centrifuged at 16,100  g
for 10 min and resuspended in 10.0 mM Na2HPO4, 2.7 mM KCl,
137 mM NaCl (pH 7.4) (PBS; Sigma-Aldrich), or in cell culture medium,
at a final protein concentration of 0.5 mg/mL (48 mM).CHO cell culture
CHO cells (CCL-61T; ATCC, Teddington, United Kingdom) were cultured
on petri dishes (Techno Plastic Products, Neuchaˆtel, Switzerland) coated
with poly-D-lysine (PDL; Sigma-Aldrich), in Dulbecco’s modified Eagle’s
medium (Gibco, Paisley, United Kingdom) containing 4.5% glutamine and
glucose, 10% inactivated fetal bovine serum, 1.0% penicillin-streptomycin,
and 1.0% nonessential amino acids (Gibco) at 37C in 5.0% CO2. The cells
were split every 4–5 days before reaching confluency. In a set of experi-
ments, CHO cells were treated with a neuraminidase (NAA) cocktail to re-
move the sialic acid group from GM1 in the plasma membrane; the cell
culture medium was replaced with a new solution of the same medium
containing 117 mU/mL of Vibrio cholerae NAA and 33 mU/mL of Arthro-
bacter ureafaciens NAA (both from Sigma-Aldrich). The cells were incu-
bated for 60 min at 37C with the NAA cocktail and subsequently rinsed
three times with PBS before further measurements.Preparation of functionalized surface for SCFS
Three-dimensional (3D) N-hydroxysuccinimidil (NHS) coverslips
(PolyAn, Berlin, Germany) were used to anchor the molecules of interest
to the glass substrate. 3D-NHS coverslips consisted of a glass substrate
that was functionalized with branched polymers presenting a combination
of reactive NHS-ester functional groups with PolyAn antifouling matrix
(PolyAn, Berlin, Germany). The functional NHS-ester reacts with the
NH2 groups of biological species (such as lysine side chains or N-termini
in proteins). The antifouling matrix prevents nonspecific attachment. This
branched polymer was covalently linked to the glass substrate of the cover-
slip and had a typical thickness of 50 nm.
Then 2.0 mL of samples containing 12 mM HypF-N in aggregated form
(OA, OB, FA, PFB) in PBS were spotted on the 3D-NHS coverslips and
incubated 15 min at room temperature in a closed chamber at 100% relative
humidity. The samples were gently rinsed twice with PBS, then all free and
nonreacted NHS-esters were blocked by incubating the coverslips with the
blocking solution (PolyAn). At the end of the incubation, the blocking so-
lution was discharged, and the samples were rinsed three times with PBS.
The functionalized substrates were used in the same day of the preparation.Cantilever functionalization and cell capture
Silicon tipless cantilevers TL1-50 with a nominal spring constant of
0.03 N/m (NanoWorld, Neuchaˆtel, Switzerland) were irradiated in an ultra-
violet/ozone cleaner (ProCleaner; Bioforce Nanosciences, Ames, IA) for
15 min before functionalization to remove organic contaminations and to
increase the hydrophilicity of the cantilever. The cantilevers were function-
alized for cell attachment with concanavalin A (Sigma-Aldrich) as
described previously (59). The actual spring constant of each cantilever
was determined in situ using the thermal noise method, as described previ-
ously (60). Following a previously reported procedure (52), a 10 mL aliquot
of a 0.15% w/w agarose solution (Sigma-Aldrich) was spread in a smallarea of the substrate until gelification, as the lack of adhesion between
the cell and the repulsive agarose significantly increased the capability of
the cantilever to capture a cell, as previously shown (52).
For cell attachment, CHO cells were removed from the petri dish via tryp-
sinization: the culturemediumwas removed, and the cells were first incubated
with 0.5% trypsin-EDTA (Gibco) for 2min and then placed in PBS buffer and
centrifuged for 5 min at 200  g. After centrifugation, the cells were resus-
pended in PBS and gently agitated; a few detached cells were injected into
the AFM liquid cell. A single cell was captured by pressing for 30 s the func-
tionalized cantilever onto a cell lying on the agarose spot with a controlled
force of 2.0 nN, and then by lifting the cantilever. Ten to fifteen minutes
were spent waiting to get a stable cell-cantilever contact. An optical image
showing a CHO cell attached to the AFM cantilever is shown in Fig. S1.SCFS
A force-distance (F-D) curve-based AFM application, SCFS, was employed
to test the interaction between a single CHO cell and the tested interactors.
SCFS experiments were carried out using a Nanowizard III system (JPK In-
struments, Berlin, Germany), coupled with an AxioObserver D1 (Zeiss,
Oberkochen, Germany) inverted optical microscope. A CellHesion module
(JPK Instruments) was used to extend to 100 mm the vertical displacement
range of the AFM.
In each experiment, the cell attached to the AFM cantilever was low-
ered at a constant speed of 5.0 mm/s until the cell made contact with the
substrate-bound protein aggregates and the preset force of 2.0 nN was
reached. The contact was kept for 30 s, maintaining the force constant
at 2.0 nN. Then the cell was retracted, lifting the cantilever at a constant
velocity of 5.0 mm/s to register the F-D curve. The force-curve length was
set at 80 mm to achieve complete detachment of the cell from the molec-
ular substrate. The F-D curves were corrected for the bending of the
cantilever (61,62) to calculate the force versus cell-sample separation
curve. After removing the baseline offset because of hydrodynamic
drag, the detachment work (W) was determined by integrating the force
over the retraction distance (cell-sample separation) below the baseline
at 0 nN of force. All the curves were processed with the JPK Data
Processing software, and the data were analyzed with OriginPro 9.1
(OriginLab, Northampton, MA).
All experiments were carried out at 37C in PBS containing 2.0 mM
CaCl2 and 2.0 mM MgCl2. The spots of the different protein aggregates
were tested sequentially with the same cell. In some cases, after the acqui-
sition of the first set of F-D curves, the Arg-Gly-Asp (RGD) tripeptide
(Sigma-Aldrich) was added at a final concentration of 200 mM to block spe-
cific integrin binding. RGD was left for 25 min before the acquisition of a
second set of F-D curves on the same positions previously tested.Cell adhesion on PDL
2.0 mL of PDL (molecular weight of 70,000; Sigma-Aldrich) dissolved in
water at a concentration of 102 M was deposited on standard glass cover-
slips and incubated for 15 min at room temperature in a closed humid
chamber (relative humidity 100%). Then the coverslips were rinsed with
deionized water. F-D curves were acquired on PDL-coated substrates as
described above. Then 48 mM of OA or OB solution in PBS were injected
in the measurement medium to a final concentration of 12 mM and left in
incubation for 25 min before the acquisition of new sets of F-D curves.Confocal scanning microscopy
CHO cells were seeded on standard PDL-coated glass coverslips using the
same procedure previously described (CHO Cell Culture) in the absence or
presence of OA or OB at a final concentration of 12 mM (monomer equiv-
alent). Similarly, CHO cells treated with the NAA cocktail for 60 min atBiophysical Journal 114, 1357–1367, March 27, 2018 1359
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with PBS before seeding on standard PDL-coated glass coverslips in the
presence of OA or OB. After seeding, the cells were fixed with 4.0%
(w/v) paraformaldehyde (SC Biotechnology, Santa Cruz, CA) in PBS at
different time intervals (24 and 48 h). The coverslips were washed once
with prewarmed PBS and fixed using 4.0% paraformaldehyde for 10 min
at room temperature. Cells were permeabilized with 0.1% Triton X-100
in PBS for 3–5 min, then 1.0% bovine serum albumin (Sigma-Aldrich) in
PBS was administered to reduce nonspecific background. For selective
F-actin staining, cells were incubated for 20 min at room temperature in
a solution of Alexa Fluor-647 phalloidin (Life Technologies, Carlsbad,
CA) diluted in PBS at a final concentration of 6.6 mM. Finally, the cells
were air-dried and mounted on microscope slides by a permanent ProLong
(Thermo Fisher Scientific, Boston, MA) antifade reagent with 40, 6-diami-
dino-2-phenylindole. Fluorescence imaging was performed with a Nikon
Inverted Microscope TiE equipped with a Nikon Confocal Laser System
(Nikon Optical, Ltd., Tokyo, Japan) with excitation at 405 and 647 nm.
The confocal microscope was set at optimal acquisition conditions of
pinhole diameter, detector gain, and laser power, and the settings were
kept constant for each analysis.RESULTS
Toxic HypF-N oligomers interact strongly with the
cell membrane
The interaction between individual CHO cells and either
toxic OAs or nontoxic OBs was studied using SCFS. Cell
interaction with the large FA (see Materials and Methods)
and PFB (see Materials and Methods) aggregates was
also investigated. OA, OB, FA, and PFB were bound to
3D-NHS coverslips. The binding to the glass substrate of
the 3D-NHS coverslips was mediated by the presence ofwith a single CHO cell as described in Materials and Methods. The same num
46 F-D curves are plotted. F-D curves were aligned at the contact point. To see
1360 Biophysical Journal 114, 1357–1367, March 27, 2018long and flexible polymeric molecules with a terminal group
(NHS) that binds covalently the NH2 groups of proteins (see
Materials and Methods). Protein aggregates were spotted
in confined areas of the 3D-NHS coverslip, identified by
markers at the bottom side of the coverslip to be easily
accessible for AFM investigation. Single CHO cells were
captured on a tipless AFM cantilever (see Materials and
Methods). A cartoon of a glass substrate functionalized
with a HypF-N aggregate and of a CHO cell captured to
the tipless AFM cantilever is shown in Fig. 1 A.
At the beginning of each experiment, the cell was in con-
tact with the functionalized substrate with a defined force
(Fig. 1 B, time point I). Then the AFM cantilever started
to move away from substrate-bound aggregates, with the
maximal adhesion force reached later; at this time, no adhe-
sion interactions had been broken, but the cantilever was de-
flected and applied a traction force to the cell (Fig. 1 B, time
point II). Then the cell began its progressive detachment
from the substrate-bound protein aggregate through several
dissociation events, generally seen in the F-D curve as a
number of jumps of the traction force followed by plateaus
(Fig. 1 B, time point III), as previously described (49). When
the cell was fully detached, a final plateau at force 0 nN
was reached (Fig. 1 B, time point IV). This experiment
yielded a F-D curve for which W, corresponding to the
gray area below the baseline at 0 nN of force (Fig. 1 C),
was the physical parameter used to quantify the interaction
between the cell and the substrate-bound protein aggregate,
representing the total energy associated with cell detach-
ment from the aggregates.FIGURE 1 (A) gives a schematic description of
all the components of the SCFS system. In (B),
the four time points of the experiment are repre-
sented as a cartoon. At the beginning the cell
is in contact with the functionalized substrate
with a defined force (I); the AFM cantilever
then starts to move away from the substrate until
the maximal adhesion force has been reached; at
this time no adhesion interactions have been
broken, but the cantilever is deflected and is
applying a traction force on the cell (II); then,
the cell begins its detachment from the
proteins linked to the substrate; the detachment
process is characterized by several rupture
events, generally defined as a number of jumps
of the traction force (III) (49); finally, the cell is
fully detached when a final plateau at force
0 nN is reached (IV). (C) shows the typical
F-D curve acquired in SCFS with the four
time points described in (B). The detachment
work (W) is the physical quantity monitored to
quantify the interaction between the cell and
the protein bound to the substrate and is repre-
sented by the gray area below the baseline
at 0 nN of force. (D) shows two batches of
F-D curves, acquired on OA (red) and OB (blue)
ber of F-D curves (n ¼ 23) was acquired for both OA and OB, and all the
this figure in color, go online.
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aggregate) were acquired for every single cell; 13 single
CHO cells were tested for a total of 252 F-D curves
(Fig. 1 D). The value of W obtained on the bare substrates,
i.e., on a portion of the 3D-NHS coverslip free of aggregates
and after blocking the NHS groups, was considered as con-
trol value (here called CTR). The values of W obtained for
the four distinct aggregate types were compared (Fig. 2).
The value ofW determined for OAwas remarkably higher
(p % 0.001) than that determined for OB (Fig. 2 B). The
W-values obtained for FA and PFB were both significantly
lower (p % 0.001) than those obtained for OA and OB
(Fig. 2 B). These data agree with the higher affinity to the
cell membrane found previously for OA with respect to
OB (13,15,18–20) and confirm the scarce interaction of
PFB and mature FA aggregates with the cell membrane
(63,64) (Fig. 2 B).GM1 partially mediates the interaction between
OA and the cell membrane
After measuring the interaction force with the cell mem-
brane of the investigated aggregates, we sought to identify
the molecules and the main chemical group(s) in the cell
membrane responsible for its strong interaction with OA;
in particular, considering our previous results, we focused
on GM1 and its sialic acid moiety. The experiments
described above were repeated on CHO cells containing
membrane GM1 lacking its negatively charged sialic acid
group after treatment with NAA (see Materials and
Methods). Over 15 F-D curves per each spot were acquired
for every single CHO cell; 13 cells were tested for a total of
245 F-D curves. In this case, the W-values determined for
OB, PFB, and FA were not different, within experimental
error, from those obtained with cells containing GM1
(Fig. 2 B), whereas a significant decrease (p % 0.001) of
the W-value was obtained on OA (Fig. 2 B) such that
the W-values recorded for OB and OA became similar
(p > 0.05) (Fig. 2 B).
This result also reveals the contribution of membrane pro-
teins and membrane lipids to the measured W-value for
detaching OA from the cell membrane. Indeed, removal of
the sialic group of the GM1 ganglioside, which is themain mediator of the lipid raft-OA interaction and associ-
ated toxicity (15,18), reduces to approximately one-half of
theW-value to detach OA for the membrane. Such a residual
W-value measured after removal of the sialic group results
from the work required to detach OA from the disordered
fluid phase of the membrane, which is not mediated by
GM1 (18), and from the protein components of the mem-
brane. We can therefore determine that the lipids in the
GM1-containing lipid rafts contribute to approximately
one-half of the overall affinity between OA and the
membrane, and that the remaining half is contributed
by membrane proteins and non-lipid-raft phospholipids.
Considering the negligible interaction of large aggregates
(FA, PFB) with the cell membrane, only the OA and OB
aggregates were further investigated.The interaction between OA/OB and cells
influences cell adhesion capability
After describing the importance of GM1 as a key determi-
nant of the force HypF-N aggregates interacting with
the cell membrane, we investigated the modulation by the
oligomers of cell adhesion to the substrate by testing the
ability of CHO cells to adhere to PDL, a widely used adhe-
sion factor and an extracellular matrix mimetic, before and
after administration of 12 mMOA or OB (monomer concen-
tration equivalent). This experiment is described schemati-
cally in Fig. 3 A. We initially tested the adhesion of a
single cell to a uniformly PDL-coated substrate at different
points of the surface (n > 20) in the absence of HypF-N
oligomers by acquiring one F-D curve per position. Then
the cell was allowed to interact with OA or OB for 25 min
before the acquisition of a new set of F-D curves in the
same positions (again, one F-D curve per position). The
experiments were repeated with 12 CHO cells for each
type of oligomer for a total of 250 F-D curves acquired
before and after oligomer administration to the cells. Being
particularly interested in the variation of W upon oligomer
administration, all W-values were normalized to those
obtained with PDL before oligomer addition (W0). After
OA administration, the detachment work was remarkably
reduced (W/W0 ¼ 0.25 5 0.07, p % 0.001) with respect
to that recorded before oligomer addition (Fig. 3 B),FIGURE 2 (A) shows a schematic representation
of the distribution of OA, OB, FA, and PFB aggre-
gates on the functionalized glass substrate. (B)
shows the mean work spent to detach the cell
from the substrate (W) for the various aggregate
types and obtained with cells treated with and
without NAA. Error bars correspond to standard
deviations. * and *** indicate p % 0.05 and
p% 0.001, respectively, relative to CTR.  indi-
cates p% 0.001 relative to CTR in the experiments
on cells untreated with NAA. ☐☐☐ indicates
p % 0.001 in the indicated comparisons. To see
this figure in color, go online.
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FIGURE 3 (A) shows a schematic representation
of the SCFS experiment performed to test CHO
cell adhesion on a standard adhesion molecule,
i.e., PDL, in the absence and presence of OA or
OB. (B) shows the mean work spent to detach the
cell from PDL-coated substrates obtained in the
absence (PDL) and in the presence of OA/OB
(þOA/þOB). Results obtained on NAA treated
cells are represented by the black bars. All the re-
sults are normalized to the corresponding value ob-
tained in the absence of protein aggregate, here
indicated as W0. Error bars correspond to standard
deviations. *** and  indicate p% 0.001 relative
to PDL. ☐☐☐ indicates p % 0.001 in the indicated
comparisons. To see this figure in color, go online.
Oropesa-Nun˜ez et al.whereas after OB administration, the detachment work
was also significantly, yet less remarkably, decreased
(W/W0¼ 0.545 0.15, p% 0.001). Indeed, theW/W0-values
measured for OA and OB were found to be significantly
different (p% 0.001), indicating that both oligomers reduce
cell-substrate interaction, yet with different efficiencies.
To better describe the role of GM1, particularly of its
sialic acid moiety, in cell-oligomer interaction, the same
experiments were repeated with NAA-treated cells. In
this case, adhesion to PDL of sialic-acid-lacking cells
was affected similarly after OA or OB administration
(p > 0.05); in particular, W/W0-values of 0.55 5 0.13
and of 0.63 5 0.13 were recorded in the presence of
OA or OB, respectively (Fig. 3 B). These data suggest
that OAs, but not OBs, interact with the cell membrane
largely through GM1 sites, in addition to membrane
proteins (unpublished data), and that the sialic acid
component of GM1 is involved in such interaction. The
raw data (nonnormalized) were shown in the Supporting
Material.RGD administration affects the affinity between
OA/OB and the cell membrane
The RGD sequence found in many extracellular matrix
components (such as fibronectin, laminin, and vitronectin)
plays a fundamental role in cell adhesion through the
interaction with a large class of integrin receptors (65). In
a recent paper, we reported the prominent role of RGD-
binding integrins in the first step of cell adhesion (52).
Therefore, to match those results with the data reported
above, we investigated the importance of the RGD sequence
for OA and OB binding to the cells by using multifunctional
substrates containing PDL. F-D curves were acquired with
single NAA-treated or NAA-untreated CHO cells before
and after the addition of a solution containing the RGD
sequence (Fig. 4 A), as described in Materials and Methods.
Over 15 F-D curves for each spot were acquired for every
single cell. Twelve untreated and 12 NAA-treated CHO
cells were tested, allowing the recording of 203 and 198
F-D curves, respectively. After RGD administration, a total1362 Biophysical Journal 114, 1357–1367, March 27, 2018number of 187 and 192 F-D curves were acquired on un-
treated or NAA-treated cells, respectively.
We found that cell adhesion to PDL was higher than cell
adhesion to OA or OB (Fig. S3). NAA treatment did not
significantly affect the interaction of CHO cells with PDL
or OB, implying the lack of participation of GM1 in such
interaction; however, NAA treatment significantly reduced
cell interaction with OA (Fig. S3), confirming the experi-
ments shown in Fig. 2 B and the importance of GM1. The
addition of the RGD sequence dramatically decreased
cell adhesion at each experimental condition, yet with
different levels of effectiveness (Fig. 4, B–G). Also, in this
case the W data were normalized to the W-value obtained
in the absence of RGD, i.e., W0. As expected, the detach-
ment work from PDL was strongly reduced after RGD
administration in NAA-untreated cells (W/W0 ¼ 0.11 5
0.06), in agreement with previous results (52). However, a
significant, yet less evident, decrease after RGD addition
was also observed with OA (W/W0 ¼ 0.31 5 0.06) and
OB (W/W0 ¼ 0.52 5 0.07).
In NAA-treated CHO cells, the observed values of W/W0
on PDL and OB after RGD injection underwent a similar
decrease, within experimental error, to those obtained
with NAA-untreated cells (W/W0 ¼ 0.16 5 0.01 and
W/W0¼ 0.595 0.04, respectively), implying that, although
involved in cell adhesion (66–69), GM1 does not play a
prominent role in PDL-cell interaction and is not involved
in the binding between cells and OB. However, a reduced
decrease of the W/W0-value on OA was observed after
RGD administration, showing the same behavior as OB
(W/W0 ¼ 0.56 5 0.06). This suggests that RGD only in
part hinders cell binding to OA via GM1 and that RGD
binding to cell membrane proteins does not directly involve
membrane gangliosides.
The reduced capability of OA and OB to bind to the cell
membrane after RGD administration has been demonstrated
by using an alternative technique, i.e., confocal fluorescence
microscopy on immunostained samples on untreated and
NAA-treated CHO cells (Fig. S4), corroborating the find-
ings obtained by AFM. From all these data, we conclude
that both HypF-N oligomers affect cell adhesion capability,
FIGURE 4 (A) shows a schematic representation
of the distribution of molecules on the glass sub-
strate. A first set of F-D curves was acquired on
the molecular spots (OA, OB, and PDL) in both
NAA-untreated and NAA-treated CHO cells; then
RGD was added at a final concentration of 200
mM and incubated for 25 min before the acquisi-
tion of a new set of F-D curves. (B)–(G) show
the mean work spent to detach the cell from PDL
(B) and (C), OA (D) and (E), and OB (F) and
(G) in NAA-untreated ((B), (D), and (F)) and
NAA-treated ((C), (E), and (G)) cells, and before
(left bars) and after (right bars) RGD addition.
All W-values were normalized to the correspond-
ing values obtained in the absence of RGD (W0).
Error bars correspond to standard deviations. ***
and  indicate p % 0.001 relative to the corre-
sponding values in the absence of RGD. ☐☐☐ indi-
cates p % 0.001 in the indicated comparison. To
see this figure in color, go online.
HypF-N Oligomers Impair Cell Adhesionyet with different efficiencies, but only in the case of OA is
this effect largely mediated by GM1, thus providing further
clues suggesting preferential oligomer interaction with
membrane lipids rather than proteins.OA affects CHO cell adhesion and proliferation
Finally, taking into consideration the close relationship be-
tween cell adhesion and proliferation, we investigated the
ability of CHO cells to adhere and proliferate on PDL-
coated substrates in the absence or presence of 12 mM OA
or OB (monomer equivalents). Confocal microscopy im-
ages were acquired 24 and 48 h after cell seeding, and the
results were compared with those obtained with control ex-
periments carried out in the absence of HypF-N oligomers
(Fig. 5). In the absence of HypF-N oligomers, the cells
were found to be healthy and spreading already at 24 h
after seeding (Fig. 5 A), with increased cell number and
spreading at 48 h (Fig. 5 E). Similar results were found
with cells exposed to OB (Fig. 5, B and F). Considering
that the effects of OB were similar in NAA-treated and
NAA-untreated cells in previous experiments, these experi-
ments were not repeated with NAA-treated cells (Fig. 5). By
contrast, after 24 h exposure, a large number of OA-exposed
cells showed a spherical shape, a morphology associated
with detached or weakly adherent cells (Fig. 5 C). This
phenotype changed further after 48 h, when the cells tended
to cluster, forming large clumps of spherical cells (Figs. 5 G
and 6). A normal phenotype was found in OA-exposed cells
seeded after treatment with NAA; in this case, cell number
and spreading were not perturbed, and cell behavior was
similar to that found in cells cultured in the absence of
HypF-N oligomers (Figs. 5, D and H and 6). High-resolu-
tion images of all samples fixed at 48 h are also shown
(Fig. 5, I–L). The level of cell spreading after 48 h was
quantified (Fig. 6).Taken together, these data confirm those reported above
on the interference of HypF-N oligomers, notably OA,
with cell adhesion to the substrate, a function needed
for cell proliferation that appears to be unaffected in
NAA-treated cells. These data also suggest that cell pro-
liferation and migration are likely to be affected by olig-
omer binding to GM1, which involves its sialic acid
moiety.DISCUSSION
It is increasingly recognized that the interaction of protein-
misfolded oligomers with the cell membrane is an early
event in the sequence of biochemical modifications that
eventually culminate with cell impairment and death.
Recent research has highlighted the importance of both
oligomer structure/morphology and membrane physico-
chemical features as key determinants of oligomer cytotox-
icity, mainly arising from different timing/conditions of
oligomer growth and different lipid content, respectively
(13,14,18,70,71). In this context, lipid rafts have emerged
as pivotal players of oligomer recruitment and cytotoxicity
(18,72,73). Therefore, it is important to use new methods
to describe in detail and accurately measure the affinities
of different types of protein aggregates to cell membranes
containing different lipid contents.
Our study provided clues on these issues by exploiting a
novel, to our knowledge, approach to investigate the inter-
actions and measure the strength of the intermolecular
bonds established between two types of HypF-N oligo-
mers with similar morphological properties yet different
cytotoxicity and the cell membrane. To do this, we deter-
mined the interaction strength between the cell membrane
of CHO cells and both toxic and nontoxic oligomers of the
sample protein HypF-N by calculating the work spent to
detach the cell from the oligomers. We found that theBiophysical Journal 114, 1357–1367, March 27, 2018 1363
FIGURE 5 Confocal microscopy images of
CHO cells 24 h (A–D) and 48 h (E–L) after seeding
on PDL-coated substrates in the absence of
HypF-N oligomers ((A), (E), and (I)), in the pres-
ence of OB ((B), (F), and (J)), in the presence of
OA ((C), (G), and (K)), and in NAA-treated cells
in the presence of OA ((D), (H), and (L)). In all
panels the blue fluorescence, produced by 40, 6-di-
amidino-2-phenylindole, shows the cell nuclei,
whereas the red fluorescence, produced by Alexa
Fluor-647 phalloidin, shows F-actin. Scale bars:
200 mm (A–H) and 10 mm (I–L). To see this figure
in color, go online.
Oropesa-Nun˜ez et al.strength of the toxic oligomers of HypF-N was approxi-
mately twice as large as that of the nontoxic species of
the same protein.
We were also able to determine the contribution of mem-
brane proteins and membrane lipids to the binding affinity
of the toxic species for the cell membrane in terms of
detachment work. This results from the following analysis.
Removal of the sialic group of the GM1 ganglioside, which
is the main mediator of the lipid-oligomer interaction and
associated toxicity, reduces to approximately one-half of
the affinity of the toxic oligomers for the membrane.
Since it was previously found that removal of the GM1FIGURE 6 The area occupied on the substrate by single CHO cells
seeded in the presence of OB (NAAþOB) is compatible with the area
measured in the CTR. Cell spreading is significantly reduced (p < 0.001)
for CHO cells seeded in the presence of toxic OA (NAAþOA). Cell adhe-
sion capability in the presence of OA is recovered in NAA treated cells
(þNAAþOA). To see this figure in color, go online.
1364 Biophysical Journal 114, 1357–1367, March 27, 2018sialic acid group from SLBs cancels out toxic OA binding
to the GM1-containing gel phase domains while maintain-
ing that to the fluid phase domains (18), the residual
affinity observed between the toxic oligomers and the
GM1-deprived cells is likely to result from oligomer bind-
ing to the disordered fluid phase of the membrane (non-lipid
rafts) and to the protein components of the membrane.
Indeed, both toxic and nontoxic HypF-N oligomers were
able to bind to membrane proteins, with the nontoxic
species displaying a slightly higher affinity (Mannini
et al., in preparation), and only toxic oligomers were able
to bind to the liquid phase of the membrane (18), suggesting
why the affinities of toxic and nontoxic species for the
GM1-deprived cells are similar for the two species. It can
therefore be concluded that the GM1-containing lipid rafts
contribute to approximately one-half of the overall affinity
between the toxic oligomers and the cell membrane, and
that the remaining half is contributed by the proteins and
non-lipid-raft phospholipids. This is an interesting outcome,
considering the unresolved question as to whether aggregate
interaction with the cell membrane involves specific or
generic lipids of the bilayer, specific or generic membrane
proteins, or both, and, in the case of membrane proteins,
whether such interaction is direct or mediated by surround-
ing lipids.
We also studied, for the first time as far as we know, the
effects of two types of toxic and nontoxic oligomers on cell
adhesion, proliferation, and spreading, providing informa-
tion that adds another piece to the oligomer toxicity jigsaw
puzzle. At the present, there is an increasing knowledge of
the biophysical, biochemical, and molecular features of
oligomer interaction with exposed cells either at lipid or at
HypF-N Oligomers Impair Cell Adhesionprotein membrane components; however, so far very few
data have been reported about the possible role played by
a third important element of the system, i.e., the extracel-
lular matrix and its protein content, in modulating the inter-
ference of amyloid oligomers with cell viability and
physiology. Yet the extracellular matrix plays pivotal roles
in cell adhesion, mobility, proliferation, and differentiation,
favoring cell viability and correct responses to environ-
mental physiological or pathological stimuli, including
those arising from the presence of amyloid oligomers
(74,75). More knowledge on this aspect appears of impor-
tance to get a more complete description of the molecular
basis of oligomer-mediated cell modifications underlying
cytotoxicity. Our data demonstrate that after RGD adminis-
tration, the mechanical work decreases, reaching roughly
the same value in all the conditions (PDL, OA, and OB,
with and without NAA), as shown in Fig. S3, C and D.
RGD injection not only blocks the integrins, but also influ-
ences ganglioside functionality. Indeed, it has been repeat-
edly reported that gangliosides play a role in cell adhesion
by binding fibronectin at its binding site, i.e., the RGD
domain (66–69). For this reason, the RGD injection has a
double effect: it blocks the direct binding of integrins to
OA (a minor fraction for OA) and it blocks/disturbs OA
binding to GM1. As a consequence, the W-value after
RGD administration is the same in the different conditions,
because in all conditions the same interactions, i.e., the
binding of PDL, OA, and OB to integrins and to the gangli-
osides, have been blocked. However, only in the case of OA
is a large part of the interaction hindered by the removal of
the sialic acid moiety from GM1 before RGD administra-
tion. This confirmed the high affinity of OA and only OA
for GM1. Overall, the data reported here suggest that the
toxic oligomers characterized by a higher affinity to the
cell membrane, particularly at GM1 sites, in addition to
the GM1 functionality, could affect the activity of a large
class of RGD-binding proteins. These two events contribute
together to influence some features of cell adhesion and
the ensuing modifications, including cell mobility and
spreading. In particular, we found that oligomer, notably
OA, binding to the cells hindered both proliferation and
spreading, and also in this case the presence of the sialic
acid component of GM1 appeared to drive the observed
modifications.
All these effects are likely to contribute to the toxicity of
OA to cells both in culture and in tissue. The results pre-
sented here provide, to our knowledge, new and valuable
hints on the mechanism of interaction between amyloid
aggregates and cellular membrane, although it must be
considered that the physiological target in neural diseases
are brain cells. These data also agree with previous results
on single-molecule tracking that showed a modification of
GM1 mobility on the membrane of SH-SY5Y cells upon
interaction with a type of Ab42 oligomers, named Aþ,
with structural and biological properties comparable tothose of OA in terms of solvent-exposed hydrophobicity
and toxicity, whereas no modifications were observed in
the presence of the other type of Ab oligomers, named
A, comparable to OB for the same structural and biolog-
ical characteristics (25).CONCLUSIONS
We applied for the first time, to our knowledge, an
AFM-based single-cell technique to the study of the interac-
tion between misfolded protein oligomers and the cell mem-
brane. In particular, by measuring the mechanical work (W)
spent to completely detach the oligomers from the cell, we
showed that toxic and nontoxic oligomers grown from
HypF-N bind to the cell membrane with different efficiency.
The oligomer-cell membrane interaction strength appears to
be a key determinant of oligomer cytotoxicity and is medi-
ated by the presence of the negatively charged sialic acid
group of the ganglioside GM1, in agreement with previously
reported data on cytotoxicity. We were also able to discrim-
inate the contributions provided by membrane lipids and
membrane proteins to oligomer-cell binding. Finally, we
showed that the presence of toxic OA significantly alters
cell adhesion capability. In particular, we observed that
the interaction of toxic OA with the cell membrane signifi-
cantly affects the functionality of a class of adhesion mole-
cules, RGD binding proteins, and that this effect requires the
presence of GM1, particularly of its negatively charged
sialic acid moiety.SUPPORTING MATERIAL
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